Why did Alexander Zverev take an injection during Wimbledon final? The French Open champion has a medical exemption needs to monitor his diabetes during matches The Independent UK · Jul 12
Wimbledon finalist Alexander Zverev is using his tennis success to raise diabetes awareness Alexander Zverev has more than just defending champion Jannik Sinner to deal with on Sunday in the Wimbledon final The Independent UK · Jul 11
Childhood Obesity in India Is Climbing: What Parents Can Do About Diet, Screen Time, and Sugar The numbers Indian parents are not seeingA 2023 analysis published in The Lancet tracked childhood obesity rates across South Asia and found that India now has over 12.5 million children with obesity, the second-highest count globally after China. The rate has more than tripled since the early 2000s. This is… Times Life · Jul 11
Once-a-week insulin launched in India, but doctors say it won't replace daily shots for all India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 to just 52 for many individuals. Experts suggest Awiqli is an additional option, not a complete replacement for daily insulin. It is best suited for patients who still produce some insulin… The Economic Times · Jul 10
How Poor Dental Health Slowly Destroys Your Gut Microbiome and Digestion Over Time Your mouth is your gut's front doorThe average adult swallows roughly 1.5 litres of saliva every day. Every millilitre carries millions of microorganisms. When your oral microbiome is balanced, that constant swallowing is harmless, most oral bacteria are acid-sensitive and die in the stomach. When your mouth is colonised by… Times Life · Jul 10
A Shot Every Two Weeks Instead of Weekly: New GLP-1 Drug Shows Strong Trial Results A new biweekly GLP-1 drug called bofanglutide showed strong blood sugar and weight loss results in a Phase 2b trial. Monthly injectables and oral pills are also in the pipeline. Medical Daily · Jul 9
1 in 4 Adults with Type 2 Diabetes Has Significant Hearing Loss, Major Review Finds A new meta-analysis finds 1 in 4 adults with type 2 diabetes has significant hearing loss. Researchers call for routine hearing tests in standard diabetes care. Medical Daily · Jul 9
Novo Nordisk launches once-weekly basal insulin 'Awiqli' in India as diabetes rates increase Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients. Awiqli aims to reduce barriers to insulin initiation, which is often delayed in India. The Indian insulin market is projected to grow significantly in… The Economic Times · Jul 9
Millions of Middle-Aged Americans Are Delaying Medical Care Until 65, and Their Health May Be Paying the Price ACA premiums tripled for some adults 50-64 in 2026, pushing many to delay cancer screenings and specialist care until Medicare at 65. Here's the health risk. Medical Daily · Jul 9
Gum Disease and Heart Disease: How Periodontal Bacteria Raise Your Cardiovascular Risk The bacteria that leave your mouth and reach your arteriesBleeding gums are not just a dental inconvenience. When the tissue around your teeth is inflamed and ulcerated, which is what periodontal disease actually is, it creates an open wound the size of your palm, lining the inside of your mouth.… Times Life · Jul 9
8 Things Your Dentist Can Diagnose About Your Overall Health From Your Mouth and Teeth Your Gums Are Bleeding, and It May Not Be About BrushingPersistent bleeding gums are the most misread signal in the dental chair. Most patients blame aggressive brushing. Dentists look further. Chronic gum bleeding is a classic early marker of gum disease, but it also shows up in vitamin C deficiency,… Times Life · Jul 9
The FDA Just Cleared the First Over-the-Counter Glucose Monitor for Children FDA cleared the first OTC glucose monitor for children ages 2+ on June 12. Here's what this means for families managing prediabetes or Type 2 diabetes. Medical Daily · Jul 8
From maternal health to influenza rates, gaps in CDC’s public health data are creating dangerous blind spots for disease tracking and prevention Public health relies on data – whether it is tracking the effectiveness of a given year’s flu vaccine, monitoring blood lead levels around the country or estimating the prevalence of diabetes. This data forms the basis for decisions such as whether a community should expand screening for diabetes and which… The Conversation · Jul 8
Diabetic Retinopathy: Why Eye Damage from Diabetes Shows No Symptoms Until Vision Is Already Gone The Eye Bleeds Before You Know ItDiabetes does not attack the eye the way an infection does, with pain, redness, and urgency. It works on the tiny blood vessels at the back of the eye, the retina, over months and years. High blood sugar makes those vessel walls weak and… Times Life · Jul 8
The Guardian - UK · Jul 7 Men’s average testosterone levels have halved in last 50 years, say scientists Exclusive: Researchers warn of ‘major crisis in male reproductive health’ partly driven by obesity and diabetes
Medical Daily · Jul 7 The FDA Just Approved the First Inhaled Mealtime Insulin for Children FDA approved Afrezza inhaled insulin for children ages 6+ in May 2026. No needle required at mealtimes. Here's what INHALE-1 found and what families should know.
Medical Daily · Jul 6 If You Take Ozempic, Wegovy, or Zepbound, Your Risk of Heat Illness Is Higher This Summer GLP-1 drugs like Ozempic and Wegovy suppress thirst, raising dehydration risk in heat. Doctors say patients must hydrate proactively. Here's the specific clinical warning for summer.
The Economic Times · Jul 4 Indian scientists recreate key human placenta functions on a chip Indian researchers have unveiled a groundbreaking "placenta-on-chip" technology, a lab-grown model replicating crucial functions of the human placenta. This innovative platform, developed by ICMR-NIRWoH and IIT Bombay, promises to unravel mysteries surrounding pregnancy, aid in understanding complications like gestational diabetes, and evaluate drug safety, potentially reducing reliance on animal testing.…
Budget and the Bees · Jul 3 Study Finds Dementia Risk Factors Hit Women Harder – High Blood Pressure, BMI and Hearing Loss Are Key As researchers continue searching for ways to reduce dementia risk, a new study is shedding light on why women may face a greater burden than men. Scientists found that several well-known risk factors—including high blood pressure, elevated body mass index (BMI), hearing loss, and diabetes—appear to have a stronger negative…
Times Life · Jul 3 Magnesium Deficiency Is Behind Your Fatigue, Anxiety, and Muscle Cramps, And Most Indian Diets Fall Short The mineral your blood test won't catchOnly about 1% of the body's magnesium circulates in the blood. The rest is stored in bone and soft tissue. This is why a standard serum magnesium test can return a normal reading while your cells are running low, and why most doctors don't…
Everybody Loves Your Money · Jun 30 Medicare GLP-1 Bridge Starts July 1: 5 Questions Big changes often sneak into healthcare quietly, but this one arrives with real impact. Starting July 1, Medicare introduces a GLP-1 bridge approach that reshapes how certain prescription therapies get handled under coverage rules. These medications, often discussed in relation to diabetes care and weight management, sit at the center…
Medical Daily · Jun 30 A New Vaccine Option Is Now Available for Kids with Diabetes, Heart Disease, or Other Chronic Conditions FDA approved Capvaxive for kids 2-17 with chronic conditions like diabetes and heart disease, June 18, 2026. Here's what families managing pediatric chronic illness need to know.
The Economic Times · Jun 30 My wife and I declared diabetes in our health insurance policy. Will it cover new illnesses too? ET Wealth Reader's Query: My wife and I have had a floater health insurance policy for over four years. We declared diabetes as a pre-existing condition. Now we have high cholesterol and mild fatty liver. Will my insurance cover pre-existing and new illnesses?
Newcastle Herald · Jun 30 'Big shock': after her diagnosis, Karen lost 30 kilograms in three years 'I had no inkling that anything was wrong.'
Medical Daily · Jun 28 June Brought Two Major FDA Advances for Children with Type 1 Diabetes: Here's What Each One Does June 2026 brought two FDA milestones for pediatric diabetes: an OTC kids' CGM and teplizumab for Stage 3 Type 1 diabetes in ages 8–17. Here's what each one does and who qualifies.